These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3010790)

  • 1. Neurochemical mechanisms of mood stabilization. Focus on electroconvulsive therapy.
    Lerer B; Shapira B
    Ann N Y Acad Sci; 1986; 462():366-75. PubMed ID: 3010790
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of electroconvulsive shock and serotonin axon lesions on beta-adrenergic and serotonin-2 receptors in rat brain.
    Kellar KJ; Stockmeier CA
    Ann N Y Acad Sci; 1986; 462():76-90. PubMed ID: 3010791
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical and neuroendocrinological effects of electroconvulsive therapy. Discussion of Part II.
    Barkai AI
    Ann N Y Acad Sci; 1986; 462():120-3. PubMed ID: 3010786
    [No Abstract]   [Full Text] [Related]  

  • 4. Receptors and the mechanism of action of ECT.
    Lerer B; Belmaker RH
    Biol Psychiatry; 1982 Apr; 17(4):497-511. PubMed ID: 6282347
    [No Abstract]   [Full Text] [Related]  

  • 5. GABA function in mood disorders: an update and critical review.
    Shiah IS; Yatham LN
    Life Sci; 1998; 63(15):1289-303. PubMed ID: 9768867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
    Davies P
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ageing and neurotransmitters].
    Nakamura S; Miyata S
    Nihon Naika Gakkai Zasshi; 1985 Oct; 74(10):1348-52. PubMed ID: 2869092
    [No Abstract]   [Full Text] [Related]  

  • 8. Alterations of brain neurotransmitter receptor binding in Huntington's chorea.
    Enna SJ; Bennett JP; Bylund DB; Snyder SH; Bird ED; Iversen LL
    Brain Res; 1976 Nov; 116(3):531-7. PubMed ID: 10053
    [No Abstract]   [Full Text] [Related]  

  • 9. Neural pathways and neurotransmitters affecting melatonin synthesis.
    Ebadi M; Govitrapong P
    J Neural Transm Suppl; 1986; 21():125-55. PubMed ID: 2875124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical aspects of depression: the past and the future?
    Jesberger JA; Richardson JS
    Int J Neurosci; 1985 Jul; 27(1-2):19-47. PubMed ID: 2991156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotransmitter receptor alterations in Parkinson's disease.
    Reisine TD; Fields JZ; Yamamura HI
    Life Sci; 1977 Aug; 21(3):335-43. PubMed ID: 197361
    [No Abstract]   [Full Text] [Related]  

  • 12. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
    Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R
    Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological challenge strategies: implications for neurochemical mechanisms in affective disorders and treatment approaches.
    Risch SC; Kalin NH; Murphy DL
    J Clin Psychopharmacol; 1981 Jul; 1(4):238-43. PubMed ID: 6117587
    [No Abstract]   [Full Text] [Related]  

  • 14. Receptor physiology and hormone secretion in affective illness.
    Psychopharmacol Bull; 1983; 19(3):479-95. PubMed ID: 6314423
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypotheses concerning the mechanism of action of antidepressant drugs.
    Maj J; Przegalinski E; Mogilnicka E
    Rev Physiol Biochem Pharmacol; 1984; 100():1-74. PubMed ID: 6146181
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurobiology and pharmacology of Huntington's disease.
    Enna SJ
    Life Sci; 1977 Jan; 20(2):205-11. PubMed ID: 190505
    [No Abstract]   [Full Text] [Related]  

  • 17. Some strategies to study the biochemical pharmacology of serotonergic function.
    Costa E
    Adv Biochem Psychopharmacol; 1982; 34():61-72. PubMed ID: 6182764
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alzheimer's disease and neurotransmitters].
    Nakamura S
    Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):30-40. PubMed ID: 1672465
    [No Abstract]   [Full Text] [Related]  

  • 19. Undernutrition and the development of brain neurotransmitter systems.
    Wiggins RC; Fuller G; Enna SJ
    Life Sci; 1984 Nov; 35(21):2085-94. PubMed ID: 6149444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine.
    Stahl SM
    CNS Spectr; 2015 Oct; 20(5):455-9. PubMed ID: 26122791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.